2.05
+0.49(+31.41%)
Currency In USD
| Previous Close | 1.56 |
| Open | 1.75 |
| Day High | 2.87 |
| Day Low | 1.75 |
| 52-Week High | 30.43 |
| 52-Week Low | 1.1 |
| Volume | 60.1M |
| Average Volume | 1.14M |
| Market Cap | 5.16M |
| PE | 0.02 |
| EPS | 90.8 |
| Moving Average 50 Days | 1.58 |
| Moving Average 200 Days | 5.32 |
| Change | 0.49 |
If you invested $1000 in GRI Bio, Inc. (GRI) since IPO date, it would be worth $0.01 as of September 12, 2025 at a share price of $2.05. Whereas If you bought $1000 worth of GRI Bio, Inc. (GRI) shares 3 years ago, it would be worth $0.11 as of September 12, 2025 at a share price of $2.05.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire Inc.
Yesterday at 12:45 PM GMT
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker data Phase 2a study fully enrolled; Topline data on track for Q3 2025 Currently available treatments for IPF are limited to only two approved dr
GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 03, 2025 1:00 PM GMT
Live webcast presentation with CEO, Dr. Marc Hertz, on September 9th at 3:00 PM ET LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline o
GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire Inc.
Aug 14, 2025 1:15 PM GMT
Live video webcast on Wednesday, August 20th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT